1. Bezlotoxumab prevents extraintestinal organ damage induced by Clostridioides difficile infection. (31st December 2022) Authors: Mileto, Steven J.; Hutton, Melanie L.; Walton, Sarah L.; Das, Antariksh; Ioannidis, Lisa J.; Ketagoda, Don; Quinn, Kylie M.; Denton, Kate M.; Hansen, Diana S.; Lyras, Dena Journal: Gut microbes Issue: Volume 14:Isuse 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗